SIRT1 and neoplasm: As shown in Figure 4A–4D, treatment with the Si-Sirt1 plus Adriamycin resulted in a significant reduction in tumor growth, compared with that of the Vector2 group via vivo imaging or macroscopic images (Figure 4A–4C).